0
ARTICLE |

Liver Photoscanning in Evaluation of Cancer Chemotherapy

DANIEL J. HANSON, MD; A. BRADLEY SOULE, MD; O. S. PETERSON, MD; CARLTON R. HAINES, MD; CLINTON D. JANNEY, PhD
Arch Surg. 1963;87(3):442-445. doi:10.1001/archsurg.1963.01310150078017.
Text Size: A A A
Published online

The liver has always been a difficult organ to evaluate. Physical examination is often inaccurate. Laboratory procedures are available to determine various parameters of liver function, but these often are not sensitive enough to appreciate other than gross changes. Plain roentgenograms of the liver also are only of value when gross changes are present, and special radiographic techniques are frequently complicated procedures.

With the advent of effective chemotherapeutic agents, and more frequent use of radiation therapy to the liver, it is advantageous to have some relatively simple method of recording their effect on primary and metastatic neoplastic disease involving the liver. Photoscanning, using a suitable recording instrument and a radioactive compound, seems to meet these requirements. In the course of a study of diagnostic techniques in neoplastic disease of the liver, we have had the opportunity to do repeat examinations on patients receiving chemotherapy. Following are representative case reports in

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs